Biolargo Inc (BLGO) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

At this time, all participants are placed on a listen-only mode. It is now my pleasure to hand the floor over to your host, Matt Kreps. Sir, the floor is yours. Thank you, and thank you everyone for joining us. With me today on the call is Dennis Calvert, our CEO, and Charles Dargan, our CFO. We want to thank you for attending the BioLargo Shareholder Town Hall today. We'll begin in just a moment. We've prepared remarks from Dennis and then taking some of the questions that were submitted through the pathways noted in our announcement press release for this call. Before I turn the call over to Dennis, though, please be advised that this presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These include, without limitation, statements regarding commercialization plans and timing, product launches, regulatory developments, partnerships and distribution arrangements, financing activity, grant funding, subsidiary evaluations, and anticipated milestones. Forward-looking statements are based on management's current expectations and assumptions that are subject to known and unknown risks and uncertainties that could cause actual results to differ materially, including those described under risk factors in the company's annual report on Form 10-K, and a subsequent quarterly report from Form 10-Q followed with the Securities and Exchange Commission. Subsidiary valuation figures present herein reflect prices paid by outside investors in private transactions that are not the result of a market for those securities. There is no assurance that any such value could be realized. The company undertakes no obligation to update any forward-looking statement except as req...